BOSTON SCIENTIFIC CORPORATION (BSX) FY2026 Q1 Balance Sheet
As of 2026-03-31
Balance Sheet
As of 2026-03-31
Swipe to see the full flow
Chart details
BOSTON SCIENTIFIC CORPORATION (BSX) FY2026 Q1 Balance Sheet
Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.
- Assets
- 44,351,000,000 US dollars
- Current assets
- 8,684,000,000 US dollars
- Non-current assets
- 35,667,000,000 US dollars
- Liabilities (calculated)
- 18,247,000,000 US dollars
- Current liabilities
- 4,571,000,000 US dollars
- Non-current liabilities
- 13,676,000,000 US dollars
- Equity
- 26,104,000,000 US dollars
- Noncontrolling interest
- 240,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- Inventories
- 3,117,000,000 US dollars
- Trade accounts receivable, net
- 3,027,000,000 US dollars
- Cash and cash equivalents
- 1,453,000,000 US dollars
- Other current assets
- 729,000,000 US dollars
- Prepaid income taxes
- 358,000,000 US dollars
- Goodwill
- 18,536,000,000 US dollars
- Other intangible assets, net
- 7,060,000,000 US dollars
- Property, plant and equipment, net
- 4,063,000,000 US dollars
- Deferred tax assets
- 3,953,000,000 US dollars
- Other long-term assets
- 2,054,000,000 US dollars
- Accrued expenses
- 2,514,000,000 US dollars
- Accounts payable
- 1,141,000,000 US dollars
- Other current liabilities
- 875,000,000 US dollars
- Current debt obligations
- 41,000,000 US dollars
- Long-term debt
- 10,988,000,000 US dollars
- Other long-term liabilities
- 2,469,000,000 US dollars
- Deferred tax liabilities
- 219,000,000 US dollars
- Additional paid-in capital
- 21,584,000,000 US dollars
- Retained earnings
- 6,912,000,000 US dollars
- Common stock, $0.01 par value - authorized 2,000,000,000 shares - 1,749,584,151 shares issued as of March 31, 2026 and 1,746,290,165 shares issued as of December 31, 2025
- 17,000,000 US dollars
- Preferred stock, $0.01 par value - authorized 50,000,000 shares - 0 shares issued as of March 31, 2026 and December 31, 2025
- 0 US dollars
- Noncontrolling interests
- 240,000,000 US dollars
- Treasury stock, at cost - 263,289,848 shares as of March 31, 2026 and December 31, 2025
- negative 2,251,000,000 US dollars
- Accumulated other comprehensive income (loss), net of tax
- negative 398,000,000 US dollars
- Gross equity (calculated)
- 28,753,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.
- The filed non-current assets lines add up to $35,666.00 M and the non-current assets total is $35,667.00 M; the $1.00 M difference is within the rounding of the filed amounts.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
